To read a recap of this past event, please Click HERE.
Friends of Cancer Research (Friends) will convene stakeholders across all health sectors to review the current methods of TMB calculation and reporting and create a consensus solution on how best to standardize them. The group will propose analytical and clinical validation studies to support a standardized method of TMB measurement and reporting, which will help improve patient care through consistent reporting in a clinical setting despite differences in the testing panel used. Ultimately, this project will help ensure consistent identification of patients who are likely to respond to Immuno-Oncology therapies.
For more information on this project please Click HERE.